View in EDS

Tafasitamab and lenalidomide in large B-cell lymphoma: real-world outcomes in a multicenter retrospective study.

Saved in:
Bibliographic Details
Title: Tafasitamab and lenalidomide in large B-cell lymphoma: real-world outcomes in a multicenter retrospective study.
Authors: Qualls DA; Lymphoma Service, Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY., Lambert N; Department of Medicine, Baylor College of Medicine, Houston, TX., Caimi PF; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH., Merrill M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Pullarkat P; Division of Hematology-Oncology, Massachusetts General Hospital, Boston, MA., Godby RC; Hematology Division, Department of Internal Medicine, Mayo Clinic, Rochester, MN., Bond DA; Division of Hematology, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, OH., Wehmeyer GT; Department of Medicine, Meyer Cancer Center, Weill Cornell Medicine and New York Presbyterian Hospital, New York, NY., Romancik J; Department of Hematology and Medical Oncology, Winship Cancer Institute at Emory University, Atlanta, GA., Amoozgar B; Department of Medicine, Washington University School of Medicine, St Louis, MO., Leslie L; Lymphoma Division, John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ., Nastoupil LJ; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX., Crombie JL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Abramson JS; Division of Hematology-Oncology, Massachusetts General Hospital, Boston, MA., Khurana A; Hematology Division, Department of Internal Medicine, Mayo Clinic, Rochester, MN., Nowakowski GS; Hematology Division, Department of Internal Medicine, Mayo Clinic, Rochester, MN., Maddocks K; Division of Hematology, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, OH., Rutherford SC; Department of Medicine, Meyer Cancer Center, Weill Cornell Medicine and New York Presbyterian Hospital, New York, NY., Kahl B; Department of Medicine, Washington University School of Medicine, St Louis, MO., Okwali M; Lymphoma Service, Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY., Buege MJ; Lymphoma Service, Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY., Seshan V; Lymphoma Service, Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY., Batlevi CL; Lymphoma Service, Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY., Salles G; Lymphoma Service, Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY.; Weill Cornell Medical College, New York, NY.
Source: Blood [Blood] 2023 Dec 28; Vol. 142 (26), pp. 2327-2331.
Publication Type: Multicenter Study; Journal Article
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37738563
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Tafasitamab and lenalidomide in large B-cell lymphoma: real-world outcomes in a multicenter retrospective study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Qualls+DA%22">Qualls DA</searchLink>; Lymphoma Service, Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY.<br /><searchLink fieldCode="AU" term="%22Lambert+N%22">Lambert N</searchLink>; Department of Medicine, Baylor College of Medicine, Houston, TX.<br /><searchLink fieldCode="AU" term="%22Caimi+PF%22">Caimi PF</searchLink>; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH.<br /><searchLink fieldCode="AU" term="%22Merrill+M%22">Merrill M</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Pullarkat+P%22">Pullarkat P</searchLink>; Division of Hematology-Oncology, Massachusetts General Hospital, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Godby+RC%22">Godby RC</searchLink>; Hematology Division, Department of Internal Medicine, Mayo Clinic, Rochester, MN.<br /><searchLink fieldCode="AU" term="%22Bond+DA%22">Bond DA</searchLink>; Division of Hematology, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, OH.<br /><searchLink fieldCode="AU" term="%22Wehmeyer+GT%22">Wehmeyer GT</searchLink>; Department of Medicine, Meyer Cancer Center, Weill Cornell Medicine and New York Presbyterian Hospital, New York, NY.<br /><searchLink fieldCode="AU" term="%22Romancik+J%22">Romancik J</searchLink>; Department of Hematology and Medical Oncology, Winship Cancer Institute at Emory University, Atlanta, GA.<br /><searchLink fieldCode="AU" term="%22Amoozgar+B%22">Amoozgar B</searchLink>; Department of Medicine, Washington University School of Medicine, St Louis, MO.<br /><searchLink fieldCode="AU" term="%22Leslie+L%22">Leslie L</searchLink>; Lymphoma Division, John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ.<br /><searchLink fieldCode="AU" term="%22Nastoupil+LJ%22">Nastoupil LJ</searchLink>; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.<br /><searchLink fieldCode="AU" term="%22Crombie+JL%22">Crombie JL</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Abramson+JS%22">Abramson JS</searchLink>; Division of Hematology-Oncology, Massachusetts General Hospital, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Khurana+A%22">Khurana A</searchLink>; Hematology Division, Department of Internal Medicine, Mayo Clinic, Rochester, MN.<br /><searchLink fieldCode="AU" term="%22Nowakowski+GS%22">Nowakowski GS</searchLink>; Hematology Division, Department of Internal Medicine, Mayo Clinic, Rochester, MN.<br /><searchLink fieldCode="AU" term="%22Maddocks+K%22">Maddocks K</searchLink>; Division of Hematology, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, OH.<br /><searchLink fieldCode="AU" term="%22Rutherford+SC%22">Rutherford SC</searchLink>; Department of Medicine, Meyer Cancer Center, Weill Cornell Medicine and New York Presbyterian Hospital, New York, NY.<br /><searchLink fieldCode="AU" term="%22Kahl+B%22">Kahl B</searchLink>; Department of Medicine, Washington University School of Medicine, St Louis, MO.<br /><searchLink fieldCode="AU" term="%22Okwali+M%22">Okwali M</searchLink>; Lymphoma Service, Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY.<br /><searchLink fieldCode="AU" term="%22Buege+MJ%22">Buege MJ</searchLink>; Lymphoma Service, Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY.<br /><searchLink fieldCode="AU" term="%22Seshan+V%22">Seshan V</searchLink>; Lymphoma Service, Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY.<br /><searchLink fieldCode="AU" term="%22Batlevi+CL%22">Batlevi CL</searchLink>; Lymphoma Service, Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY.<br /><searchLink fieldCode="AU" term="%22Salles+G%22">Salles G</searchLink>; Lymphoma Service, Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY.; Weill Cornell Medical College, New York, NY.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227603509%22">Blood</searchLink> [Blood] 2023 Dec 28; Vol. 142 (26), pp. 2327-2331.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Multicenter Study; Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7603509 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1528-0020 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200064971%22">00064971 </searchLink><i>NLM ISO Abbreviation: </i>Blood <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37738563
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1182/blood.2023021274
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2327
    Titles:
      – TitleFull: Tafasitamab and lenalidomide in large B-cell lymphoma: real-world outcomes in a multicenter retrospective study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Qualls DA
      – PersonEntity:
          Name:
            NameFull: Lambert N
      – PersonEntity:
          Name:
            NameFull: Caimi PF
      – PersonEntity:
          Name:
            NameFull: Merrill M
      – PersonEntity:
          Name:
            NameFull: Pullarkat P
      – PersonEntity:
          Name:
            NameFull: Godby RC
      – PersonEntity:
          Name:
            NameFull: Bond DA
      – PersonEntity:
          Name:
            NameFull: Wehmeyer GT
      – PersonEntity:
          Name:
            NameFull: Romancik J
      – PersonEntity:
          Name:
            NameFull: Amoozgar B
      – PersonEntity:
          Name:
            NameFull: Leslie L
      – PersonEntity:
          Name:
            NameFull: Nastoupil LJ
      – PersonEntity:
          Name:
            NameFull: Crombie JL
      – PersonEntity:
          Name:
            NameFull: Abramson JS
      – PersonEntity:
          Name:
            NameFull: Khurana A
      – PersonEntity:
          Name:
            NameFull: Nowakowski GS
      – PersonEntity:
          Name:
            NameFull: Maddocks K
      – PersonEntity:
          Name:
            NameFull: Rutherford SC
      – PersonEntity:
          Name:
            NameFull: Kahl B
      – PersonEntity:
          Name:
            NameFull: Okwali M
      – PersonEntity:
          Name:
            NameFull: Buege MJ
      – PersonEntity:
          Name:
            NameFull: Seshan V
      – PersonEntity:
          Name:
            NameFull: Batlevi CL
      – PersonEntity:
          Name:
            NameFull: Salles G
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 28
              M: 12
              Text: 2023 Dec 28
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1528-0020
          Numbering:
            – Type: volume
              Value: 142
            – Type: issue
              Value: 26
          Titles:
            – TitleFull: Blood
              Type: main
ResultId 1